Delivery Order SPE2DB20D2014-SPE2DB24FC24B
- Not listed
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA). The $1,385.37 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $10,136.69, was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $3,928.62 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of March 8, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,357.92 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 22, 2023 and was awarded on August 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA). The contract, valued at $7,580.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Humira(CF) Pen 40 mg/0.4 mls. The contract has a firm fixed price of $8,418.89 and a completion date of May 2, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a range of...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication to the Defense Logistics Agency (DLA), a defense agency. The $1,510.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 15, 2025, with a completion date of July 16, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Medical Supply Chain, a subcomponent of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $43,318.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FC24BDelivery Order
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL medical supplies to the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, in the amount of $3,238.56 on June 13, 2024 with a completion date of June 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order award is part of that larger IDC. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 6/13/24 |